Findings were based on assessments of 149 drugs partnerships in England. They showed in 95% of partnerships, less than half of service users had a recorded test date for hepatitis C.
A further 95% of partnerships offered hepatitis B vaccinations to less than three-quarters of service users.
More out-of-hours needle exchanges are necessary, says the report, with 44% of partnerships rated as ‘weak’ in this area.
Anna Walker, the Healthcare Commission’s chief executive, said: “Partnerships must now concentrate on driving improvements in the key areas highlighted by the review, in order to provide an equal service to all patients across the country. It is also important that partnerships really understand the needs in their area for these services and provides them accordingly.”